Imagine having surgery and the pain never fully leaves. This condition, called chronic post-surgical pain, is a real and debilitating problem for some patients. A new review of medical literature looked at what might help prevent it. The analysis suggests that for certain complex surgeries, using regional anesthesia—like targeted nerve blocks—could be a key part of preventing pain from becoming chronic. The review also highlights that using specific non-opioid medications around the time of surgery might help patients avoid getting stuck on opioid painkillers long-term. It's important to know this isn't a new study with fresh data, but a synthesis of what existing research has shown. The authors didn't report specific numbers on how much these approaches help or any safety issues. They conclude that preventing long-term pain requires a personalized plan before surgery, one that uses these targeted pain control methods. The takeaway is that the tools might already exist in the anesthesia toolkit to make a real difference for patients at high risk.
Narrative review supports regional anesthesia and targeted non-opioids for chronic post-surgical pain and opioid useCan better pain control during surgery prevent long-term suffering?
AI-generated summary of the cited source, checked by automated accuracy review. How we work
A narrative mini-review synthesized evidence from various study types, including RCTs and systematic reviews, on perioperative interventions for chronic post-surgical pain (CPSP) and postoperative chronic opioid use (COU). The review did not report a specific study population, sample size, setting, or comparator. It concluded that evidence supports the use of regional anesthesia (e.g., neuroaxial or paravertebral blocks) for CPSP prevention in high-risk procedures and that targeted systemic non-opioids may help mitigate opioid consumption and chronicity. No specific effect sizes, absolute numbers, or statistical significance measures were reported for these interventions.
Safety and tolerability data for the interventions were not reported in the review. The authors propose that managing CPSP and COU requires a precision medicine approach with thorough preoperative risk stratification and implementation of targeted, mechanism-based perioperative analgesia.
Key limitations stem from the review's design. As a narrative synthesis, it does not provide new primary data or report specific quantitative outcomes. The evidence strength for the supported interventions cannot be assessed from the provided summary. Practice relevance is restrained; the review suggests a framework for perioperative care but does not offer specific, measurable guidance on intervention efficacy.